7/17/2025
Read More
Shortened treatment benefits some with pre-extensively drug-resistant TB, but not all
A randomized trial finds that a 6- to 9-month regimen of bedaquiline, delamanid, linezolid, and clofazimine worked better in pre-XDR TB patients with limited disease.
Read More